Related Experiment Video
Updated: Mar 14, 2026
04:38
A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
10.9K
Psychopharmacology and stroke
1a Psychiatric Consultant Southern New England Rehabilitation Center Assistant Professor, Psychiatry and Human Behavior Brown University Providence , Rhode Island Psychiatrist St Luke's Hospital New Bedford , Massachusetts.
Topics in Stroke Rehabilitation
|September 30, 2016
Summary
Psychopharmacology in stroke patients demands precise diagnosis and medication management to aid recovery. This review details the clinical use of various psychotropic drugs, including antipsychotics and antidepressants, for stroke patients.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Pharmacology
Background:
- Stroke can lead to various psychiatric complications requiring pharmacological intervention.
- Psychotropic medications offer potential benefits but also risks in post-stroke patients.
- Careful consideration of drug selection and monitoring is crucial for optimal outcomes.
Purpose of the Study:
- To review the specific clinical implications of using psychotropic medications in stroke patients.
- To highlight the importance of accurate diagnosis and appropriate drug selection.
- To discuss the avoidance of adverse effects that may impede recovery.
Main Methods:
- Literature review focusing on psychopharmacology in the context of stroke.
- Analysis of clinical data regarding the use of specific drug classes.
- Examination of potential interactions and side effects relevant to stroke recovery.
Main Results:
- Antipsychotic, antidepressant, psychostimulant, antimanic, and anxiolytic agents have specific roles in managing stroke-related conditions.
- Medication selection must be tailored to individual patient needs and potential interactions.
- Monitoring for efficacy and side effects is essential for safe and effective treatment.
Conclusions:
- Effective psychopharmacological management in stroke requires a nuanced approach.
- Understanding the specific benefits and risks of each agent is critical.
- Optimizing medication use can significantly improve functional recovery and quality of life for stroke survivors.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
649
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
649
01:28Drug Therapy
364
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
364
01:28Psychosis and Antipsychotic Drugs: Overview
1.1K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.1K
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.3K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.3K
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
93
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
93